The Incoming Influenza Season - China, the United Kingdom, and the United States, 2021-2022

被引:17
|
作者
Han, Shasha [1 ,2 ]
Zhang, Ting [3 ]
Lyu, Yan [4 ]
Lai, Shengjie [5 ]
Dai, Peixi [6 ]
Zheng, Jiandong [6 ]
Yang, Weizhong [3 ]
Zhou, Xiaohua [1 ,7 ,8 ]
Feng, Luzhao [3 ]
机构
[1] Peking Univ, Beijing Int Ctr Math Res, Beijing, Peoples R China
[2] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA
[3] Chinese Acad Med Sci & Peking Union Med Coll, Sch Populat Med & Publ Hlth, Beijing, Peoples R China
[4] Peking Univ, Acad Adv Interdisciplinary Studies, Beijing, Peoples R China
[5] Univ Southampton, Sch Geog & Environm Sci, WorldPop, Southampton, Hants, England
[6] Chinese Ctr Dis Control & Prevent, Div Infect Dis, Beijing, Peoples R China
[7] Peking Univ, Sch Publ Hlth, Dept Biostat, Beijing, Peoples R China
[8] Peking Univ, Natl Engn Lab Big Data Anal & Appl Technol, Beijing, Peoples R China
来源
CHINA CDC WEEKLY | 2021年 / 3卷 / 49期
基金
比尔及梅琳达.盖茨基金会;
关键词
COVID-19;
D O I
10.46234/ccdcw2021.253
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: Seasonal influenza activity has declined globally since the widespread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission. There has been scarce information to understand the future dynamics of influenza - and under different hypothesis on relaxation of non pharmaceutical interventions (NPIs) in particular - after the disruptions to seasonal patterns. Methods: We collected data from public sources in China, the United Kingdom, and the United States, and forecasted the influenza dynamics in the incoming 2021-2022 season under different NPIs. We considered Northern China and Southern China separately, due to the sharp difference in the patterns of seasonal influenza. For the United Kingdom, data were collected for England only. Results: Compared to the epidemics in 2017-2019, longer and blunter influenza outbreaks could occur should NPIs be fully lifted, with percent positivity varying from 10.5 to 18.6 in the studying regions. The rebounds would be smaller if the mask wearing intervention continued or the international mobility stayed low, but sharper if the mask-wearing intervention was lifted in the middle of influenza season. Further, influenza activity could stay low under a much less stringent mask-wearing intervention coordinated with influenza vaccination. Conclusions: The results added to our understandings of future influenza dynamics after the global decline during the coronavirus disease 2019 (COVID-19) pandemic. In light of the uncertainty on the incoming circulation strains and the relatively low negative impacts of mask wearing on society, our findings suggested that wearing mask could be considered as an accompanying mitigation measure in influenza prevention and control, especially for seasons after long periods of low-exposure to influenza viruses. Seasonal influenza activity declines globally during the during the coronavirus disease 2019 (COVID-19) pandemic (1-4). For instance, in China, influenza activity, as measured by percentage of submitted specimens testing positive, dropped from 11.8% to 2.0% in 2020-2021 influenza season, compared to the past 5 years (5). The long-period of low-exposure to influenza viruses adds great uncertainty on preparedness for the incoming 2021-2022 influenza season. Influenza vaccination is one of the most effective measures in seasonal influenza prevention and control, but with only a few influenza viruses circulating, it could be difficult to determine the targeted strains for vaccination. In this context, it is of primary importance to identify alternative mitigation measures for the incoming 2021-2022 influenza season, the first season after long periods of virtually no influenza outbreaks worldwide. Using data from China, the United Kingdom, and the United States, we forecasted the influenza activity in the incoming 2021-2022 influenza season under hypothetical scenarios without non-pharmaceutical interventions (NPIs) and with different assumptions on mask-wearing and mobility levels.
引用
下载
收藏
页码:1039 / 1045
页数:7
相关论文
共 50 条
  • [21] Clinical characteristics of outpatients with influenza-B-associated pneumonia and molecular evolution of influenza B virus in Beijing, China, during the 2021-2022 influenza season
    Wang, Yanxin
    Liu, Yafen
    Wang, Yue
    Mai, Huan
    Chen, Yuanyuan
    Zhang, Yifan
    Ji, Ying
    Cong, Xu
    Gao, Yan
    ARCHIVES OF VIROLOGY, 2024, 169 (02)
  • [22] The emergence of influenza B as a major respiratory pathogen in the absence of COVID-19 during the 2021-2022 flu season in China
    Chang, De
    Lin, Mingui
    Song, Ning
    Zhu, Zhantao
    Gao, Jing
    Li, Shujun
    Liu, Hongmei
    Liu, Dezhi
    Zhang, Yu
    Sun, Wenkui
    Zhou, Xuan
    Yang, Bin
    Li, Yongjun
    Wang, Lili
    Xiao, Zhiqing
    Li, Kailong
    Xing, Lihua
    Xie, Lixin
    Sharma, Lokesh
    VIROLOGY JOURNAL, 2023, 20 (01)
  • [23] "Dunkirk Spirit:" Differences Between United Kingdom and United States Responses to Pandemic Influenza
    Sorell, Tom
    Draper, Heather
    Damery, Sarah
    Ives, Jonathan
    AMERICAN JOURNAL OF BIOETHICS, 2009, 9 (11): : 21 - 22
  • [24] AWARDS IN UNITED KINGDOM AND UNITED STATES
    不详
    NATURE, 1961, 192 (479) : 212 - +
  • [25] Evolution of the National Innovation Systems of the United States, the United Kingdom, China and Iran
    Volchik, V. V.
    Tsygankov, S. S.
    Maskaev, A., I
    ECONOMIC AND SOCIAL CHANGES-FACTS TRENDS FORECAST, 2023, 16 (03) : 284 - 301
  • [26] Recommendations for Prevention and Control of Influenza in Children, 2021-2022
    Chaparro, Juan D.
    Michel, Jeremy J.
    Kimberlin, David W.
    Barnett, Elizabeth D.
    Lynfield, Ruth
    Sawyer, Mark H.
    Bernstein, Henry H.
    Meissner, H. Cody
    Cohn, Amanda C.
    Farizo, Karen M.
    Halasa, Natasha B.
    Kim, David
    Medina, Eduardo Lopez
    Moore, Denee
    Moore, Scot B.
    Panagiotakopoulos, Lakshmi
    Sauve, Laura
    Silverman, Neil S.
    Starke, Jeffrey R.
    Tomashek, Kay M.
    PEDIATRICS, 2021, 148 (04)
  • [27] Comparison of factors associated with seasonal influenza and COVID-19 booster vaccination coverage among healthcare personnel working at acute care hospitals during 2021-2022 influenza season, National Healthcare Safety Network, United States
    Meng, Lu
    Bell, Jeneita
    Soe, Minn
    Edwards, Jonathan
    Lymon, Hoody
    Barbre, Kira
    Reses, Hannah
    Patel, Avni
    Wong, Emily
    Dudeck, Margaret
    Huynh, Cam-Van
    Rowe, Theresa
    Dubendris, Heather
    Benin, Andrea
    PREVENTIVE MEDICINE, 2024, 179
  • [28] IMPACT OF COVID-19 ON INFLUENZA VACCINE SALES IN FRANCE, UNITED KINGDOM AND UNITED STATES
    Ngami, A.
    Christie, T.
    Menin, G.
    Guelfucci, F.
    Bianic, F.
    Net, P.
    VALUE IN HEALTH, 2022, 25 (01) : S267 - S267
  • [29] United States Influenza 2022-2023 Season Characteristics as Inferred from Wastewater Solids, Influenza Hospitalization, and Syndromic Data
    Schoen, Mary E.
    Bidwell, Amanda L.
    Wolfe, Marlene K.
    Boehm, Alexandria B.
    ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2023, 57 (49) : 20542 - 20550
  • [30] Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022
    Chung, Essie R.
    Kim, Sam S.
    Kondor, Rebecca J.
    Smith, Catherine
    Budd, Alicia P.
    Tartof, Sam Y.
    Florea, Ana
    Talbot, H. Keipp
    Grijalva, Carlos G.
    Wernli, Karen J.
    Phillips, C. Hallie
    Monto, Arnold S.
    Martin, Emily T.
    Belongia, Edward A.
    McLean, Huong Q.
    Gaglani, Manjusha
    Reis, Michael
    Geffel, Krissy Moehling
    Nowalk, Mary Patricia
    DaSilva, Juliana
    Keong, Lisa M.
    Stark, Thomas J.
    Barnes, John R.
    Wentworth, David E.
    Brammer, Lynnette
    Burns, Erin
    Fry, Alicia M.
    Patel, Manish M.
    Flannery, Brendan
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2022, 71 (10): : 365 - 370